Skip to content
Showing 11 - 20 of 4912 results.
A strategic decision-making and team-building exercise for hospital executives—developed at Columbia University Mailman School of Public Health—now includes a simulated pandemic.
View the CUIMC Update, a weekly e-newsletter featuring medical center news and the accomplishments of our faculty, staff, and trainees.
New images of Wnt, a signaling protein mutated in some cancers, in complex with its specific carrier, reveals atomic-level details of the molecules and a potential new drug target.
The pace is worrying some experts. “I do feel concern,” said Dr. Wafaa El-Sadr, an epidemiology professor at Columbia University.
Viral load, the amount of virus detected in a PCR nasal swab, can be used to predict patient outcomes and guide quarantine decisions, Daniel Griffin says.
The results suggest that knowing the so-called viral load could help doctors predict a patient’s course, said Dr. Daniel Griffin, an infectious disease physician at Columbia University in New York.
Editor's Note: Joan Bregstein, the author of this article, is an associate professor of pediatrics in the Department of Emergency Medicine.
Columbia neurologist Anna Nordvig says that some COVID-19 patients experience cognitive and neuropsychiatric symptoms, like brain fog, that can persist for months, though others recover more quickly.
When the virus arrived in New York City, VP&S clinicians were redeployed to areas in need, researchers pivoted to COVID research, and students graduated early to help “bend the curve.”
A new study conducted at Columbia and other centers found that 80% of patients with a type of slow-growing lymphoma achieved a complete remission with a single infusion of CAR T-cell immunotherapy.